Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Both short and long term effects of androgen deficiency and steroid replacement therapy on skeletal homeostasis were investigated in aged (13-month-old) male rats. The animals were either sham operated (n = 28) or orchidectomized (orch; n = 89). The orch animals were divided into 5 groups; 26 rats received an empty sc Silastic implant (orch), all others received an implant containing testosterone (T), 5 alpha-dihydrotestosterone (DHT), 17 beta-estradiol (E2), or nandrolone (Nandro; 15-16 rats in each group). Half of the rats were killed 1 month (short term experiment) after implantation; the others were killed 4 months after implantation (long term experiment). Short term androgen deficiency caused a significant increase in both serum osteocalcin and histomorphometric parameters of bone turnover measured at the proximal tibial metaphysis, but not in a significant decrease in bone mass at this site. This increase in bone turnover was prevented not only by T and DHT, but also by E2 and Nandro. Long term androgen deficiency resulted in a decrease in the calcium content of both tibia and lumbar vertebrae. Cancellous bone volume in the proximal tibial metaphysis was +/- 50% lower in the orch group (P less than 0.001) 4 months after orchidectomy. At the same time, cortical bone was lost in orch rats; femoral cortical thickness was reduced by 12% (P less than 0.01), and cortical density tended to be lower. T, DHT, E2, or Nandro treatment completely prevented this decrease in cortical thickness and density. T and Nandro were also able to prevent the cancellous bone loss. DHT could only partly prevent cancellous bone loss. E2 treatment resulted not only in a sustained decrease in both serum osteocalcin concentrations and histomorphometric indices of bone turnover, but also in a net gain of cancellous bone volume (P less than 0.05 vs. sham). No significant differences in serum concentrations of vitamin D metabolites or nephrogenous cAMP were observed between groups in both short and long term experiments. We conclude that bone mass in aged male rats was significantly decreased 4 months after orchidectomy, preceded by an early increase in bone turnover. Both the early increase in bone turnover and the later decrease in bone mass were prevented by aromatizable and nonaromatizable androgens by estrogen and by nandralone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of androgen receptors in normal human osteoblast-like cells.
Colvard, D. S., Eriksen, E. F., Keeting, P. E., Wilson, E. M., Lubahn, D. B., French, F. S., Riggs, B. L., & Spelsberg, T. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.854 · Cited by 462
Cited by
Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757
Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
“In addition, T antagonizes periosteal expansion in ovx rats (234), but increases periosteal bone formation in orch rats (209, 221, 234) (Table 7).”
BackgroundMethodInfluentialSelf-citationManolagas, S. C. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.385 · Cited by 517
Compston, J. E. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.419 · Cited by 511
Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice
Vidal, O., Lindberg, M. K., Hollberg, K., Baylink, D. J., Andersson, G., Lubahn, D. B., Mohan, S., Gustafsson, J.-Å., & Ohlsson, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5474 · Cited by 386
Sims, N. A., Dupont, S., Krust, A., Clement-Lacroix, P., Minet, D., Resche-Rigon, M., Gaillard-Kelly, M., & Baron, R. (2002) · Bone · doi:10.1016/s8756-3282(01)00643-3 · Cited by 353
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis
Locatelli, V., & Bianchi, V. E. (2014) · International Journal of Endocrinology · doi:10.1155/2014/235060 · Cited by 307
Differential Effects of Androgens and Estrogens on Bone Turnover in Normal Men
Leder, B. Z., LeBlanc, K. M., Schoenfeld, D. A., Eastell, R., & Finkelstein, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021036 · Cited by 283
“Moreover, in cell culture, both aromatizable and nonaromatizable androgens reduce the resorption activity of osteoclasts (5), and in rodents, administration of either aromatizable or nonaromatizable androgens prevents orchidectomy-induced osteoclastogenesis and bone loss (6, 7, 37).”
BackgroundRaisz, L. G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.37 · Cited by 278
Cytokines, bone remodeling, and estrogen deficiency: a 1998 update
JILKA, R. (1998) · Bone · doi:10.1016/s8756-3282(98)00077-5 · Cited by 255
Androgens regulate bone resorption activity of isolated osteoclasts in vitro
Pederson, L., Kremer, M., Judd, J., Pascoe, D., Spelsberg, T. C., Riggs, B. L., & Oursler, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.505 · Cited by 123
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5359 · Cited by 126
“Moreover, the loss of bone in these animals is associated with histomorphometric evidence of increased osteoblast and osteoclast surfaces, numbers of osteoclasts, bone formation rate, and bone turnover (36, 37).”
Vandenput, L., Boonen, S., Van Herck, E., Swinnen, J. V., Bouillon, R., & Vanderschueren, D. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.11.2080 · Cited by 100
Self-citationVanderschueren, D., Vandenput, L., Boonen, S., Van Herck, E., Swinnen, J. V., & Bouillon, R. (2000) · Endocrinology · doi:10.1210/endo.141.5.7472 · Cited by 88
Self-citationGunness, M., & Orwoll, E. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101117 · Cited by 86
Chen, Q., Kaji, H., Sugimoto, T., & Chihara, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02160-3 · Cited by 63
Androgen resistance and deficiency have different effects on the growing skeleton of the rat
Vanderschueren, D., Van Herck, E., Geusens, P., Suiker, A., Visser, W., Chung, K., & Bouillon, R. (1994) · Calcified Tissue International · doi:10.1007/bf00425875 · Cited by 45
“In vivo studies in aged male orchidectomized rats also show that estrogen administration may prevent cancellous osteopenia [23].”
BackgroundMethodSelf-citationEffect of aromatase inhibition on bone metabolism in elderly hypogonadal men
Leder, B. Z., & Finkelstein, J. S. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1890-8 · Cited by 44
“Animal studies have consistently demonstrated an integral role for androgen receptor stimulation in maintaining normal bone turnover [63–65], and testosterone has been shown to prevent orchidectomy-induced bone loss in mice lacking the estrogen receptor-a [66].”
BackgroundLuo, S., Labrie, C., Bélanger, A., & Labrie, F. (1997) · Endocrinology · doi:10.1210/endo.138.8.5345 · Cited by 34
Kim, N. R., David, K., Corbeels, K., Khalil, R., Antonio, L., Schollaert, D., Deboel, L., Ohlsson, C., Gustafsson, J.-Å., Vangoitsenhoven, R., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab045 · Cited by 21
Self-citation
Metadata
- Authors
- Vanderschueren, D.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1992-05-01
- Volume
- 130
- Issue
- 5
- Pages
- 2906-2916
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2031689741
- Cited by
- 222
- References
- 1
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.